Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

297 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The side effects of Bacillus Calmette-Guerin in the treatment of Ta T1 bladder cancer do not predict its efficacy: results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial.
Sylvester RJ, van der Meijden AP, Oosterlinck W, Hoeltl W, Bono AV; EORTC Genito-Urinary Tract Cancer Group. Sylvester RJ, et al. Among authors: oosterlinck w. Eur Urol. 2003 Oct;44(4):423-8. doi: 10.1016/s0302-2838(03)00371-3. Eur Urol. 2003. PMID: 14499675 Clinical Trial.
Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies.
Brausi M, Collette L, Kurth K, van der Meijden AP, Oosterlinck W, Witjes JA, Newling D, Bouffioux C, Sylvester RJ; EORTC Genito-Urinary Tract Cancer Collaborative Group. Brausi M, et al. Among authors: oosterlinck w. Eur Urol. 2002 May;41(5):523-31. doi: 10.1016/s0302-2838(02)00068-4. Eur Urol. 2002. PMID: 12074794
Maintenance Bacillus Calmette-Guerin for Ta T1 bladder tumors is not associated with increased toxicity: results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial.
van der Meijden AP, Sylvester RJ, Oosterlinck W, Hoeltl W, Bono AV; EORTC Genito-Urinary Tract Cancer Group. van der Meijden AP, et al. Among authors: oosterlinck w. Eur Urol. 2003 Oct;44(4):429-34. doi: 10.1016/s0302-2838(03)00357-9. Eur Urol. 2003. PMID: 14499676 Clinical Trial.
[EAU Recommendations 2001. "Guidelines on bladder cancer"].
Oosterlinck W, Lobel B, Jackse G, Malmström PU, Stöckle M, Strenberg C; European Association of Urology. Oosterlinck W, et al. Prog Urol. 2002 Nov;12(5):1161-3. Prog Urol. 2002. PMID: 12536941 French. No abstract available.
297 results